These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20835264)

  • 21. Statins improve NASH via inhibition of RhoA and Ras.
    Schierwagen R; Maybüchen L; Hittatiya K; Klein S; Uschner FE; Braga TT; Franklin BS; Nickenig G; Strassburg CP; Plat J; Sauerbruch T; Latz E; Lütjohann D; Zimmer S; Trebicka J
    Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G724-G733. PubMed ID: 27634010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling.
    Marunouchi T; Matsumura K; Fuji E; Iwamoto A; Tanonaka K
    Pharmacology; 2024; 109(1):43-51. PubMed ID: 38016432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
    Rose M; Balakumar P; Singh M
    Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein-enriched extracts from housefly (Musca domestica) maggots alleviates atherosclerosis in apolipoprotein E-deficient mice by promoting bile acid production and consequent cholesterol consumption.
    Xian C; Lai D; Liu J; Li S; Cao J; Chen K; Liang D; Fu N; Wang Y; Xiao M
    Arch Insect Biochem Physiol; 2022 Oct; 111(2):e21951. PubMed ID: 35791048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein A-I Mimetic Peptide D-4F Reduces Cardiac Hypertrophy and Improves Apolipoprotein A-I-Mediated Reverse Cholesterol Transport From Cardiac Tissue in LDL Receptor-null Mice Fed a Western Diet.
    Han J; Zhang S; Ye P; Liu YX; Qin YW; Miao DM
    J Cardiovasc Pharmacol; 2016 May; 67(5):412-7. PubMed ID: 26828321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosuvastatin inhibits TIMP-2 and promotes myocardial angiogenesis.
    Siddiqui AJ; Gustafsson T; Sylven C; Crisby M
    Pharmacology; 2014; 93(3-4):178-84. PubMed ID: 24854110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet.
    Zheng F; Cai Y
    Lipids Health Dis; 2019 Jan; 18(1):6. PubMed ID: 30611282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway.
    Liu J; Shen Q; Wu Y
    Life Sci; 2008 May; 82(19-20):991-6. PubMed ID: 18400235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
    Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosuvastatin inhibits inflammatory response and resists fibrosis after myocardial infarction.
    Bao JW; Sun B; Ma PP; Gai YS; Sun WZ; Yu HQ; Li J
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):238-245. PubMed ID: 29364492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
    Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
    Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.
    Patel R; Nagueh SF; Tsybouleva N; Abdellatif M; Lutucuta S; Kopelen HA; Quinones MA; Zoghbi WA; Entman ML; Roberts R; Marian AJ
    Circulation; 2001 Jul; 104(3):317-24. PubMed ID: 11457751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in PPAR gene expression and myocardial tolerance to ischaemia: relevance to pleiotropic effects of statins.
    Ravingerová T; Adameová A; Kelly T; Antonopoulou E; Pancza D; Ondrejcáková M; Khandelwal VK; Carnická S; Lazou A
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1028-36. PubMed ID: 20029539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
    Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
    Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of losartan and simvastatin on collagen content, myocardial expression of MMP-2 mRNA, MMP-9 mRNA and TIMP-1 mRNA, TIMP-2 mRNA in pressure overload rat hearts].
    Xing XQ; Xu J; Lü XW; Huang Y; Zhu PL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Oct; 37(10):887-91. PubMed ID: 20137537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
    Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
    Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
    Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
    Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.
    Hansmann G; Wagner RA; Schellong S; Perez VA; Urashima T; Wang L; Sheikh AY; Suen RS; Stewart DJ; Rabinovitch M
    Circulation; 2007 Mar; 115(10):1275-84. PubMed ID: 17339547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes reduces aortic endothelial gap junctions in ApoE-deficient mice: simvastatin exacerbates the reduction.
    Hou CJ; Tsai CH; Su CH; Wu YJ; Chen SJ; Chiu JJ; Shiao MS; Yeh HI
    J Histochem Cytochem; 2008 Aug; 56(8):745-52. PubMed ID: 18443364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E.
    Wang YX; Martin-McNulty B; Huw LY; da Cunha V; Post J; Hinchman J; Vergona R; Sullivan ME; Dole W; Kauser K
    Atherosclerosis; 2002 May; 162(1):23-31. PubMed ID: 11947894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.